Nonconvulsive status epilepticus in two patients receiving tiagabine treatment

Epilepsia

Volumn 39, Issue 6, 1998, Pages 671-674

  Eckardt, Karin M ^a   Steinhoff, Bernhard J ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Atypical absence; Epilepsy; Nonconvulsive status epilepticus; Paradoxical effect; Tiagabine

Indexed keywords

CARBAMAZEPINE; DIAZEPAM; GABAPENTIN; TIAGABINE;

ABSENCE; ADULT; ARTICLE; CASE REPORT; DOG; DRUG EFFICACY; EPILEPTIC STATE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACTABLE EPILEPSY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REMISSION; RISK FACTOR;

ADULT; ANTICONVULSANTS; DRUG THERAPY, COMBINATION; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPSY, ABSENCE; FEMALE; HUMANS; NIPECOTIC ACIDS; STATUS EPILEPTICUS;

EID: 0031747791     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1998.tb01438.x     Document Type: Article

References (15)

1. Oestergaard LH, Gram L, Dam M. Potential antiepileptic drugs. Tiagabin. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic drugs. 4th ed. New York: Raven Press, 1995:1057-61.
2. Bauer J, Hilz MJ, Sappke U, Stefan H. Klinische Symptomatologie und therapie der status epileptici. Fortschr Neurol Psychiatr 1992;60:181-205.
3. Ben-Menachem E. International experience with tiagabine add-on therapy. Epilepsia 1976;36 (suppl 6):S14-21.
4. Fromm GH. Gabapentin [Discussion]. Epilepsia 1994;35 (suppl 5):S77-80.
5. Johnson SD, Tarby TJ, Sidell D. Carbamazepine-induced seizures [Letter]. Ann Neurol 1984;16:392-3.
6. Levy LL, Fenichel GM. Diphenylhydenton activated seizures. Neurology 1965;15:716-22.
7. Leppik IE. Tiagabine: the safety landscape. Epilepsia 1996;36 (suppl 6):S10-3.
8. Shinnar S, Berg A, Hauser WA, et al. Evaluation of the incidence of status epilepticus in association with tiagabine therapy [Abstract]. Epilepsia 1997;38 (suppl 3):S65.
9. Coenen AML, Blezer EHM, van Luijtelaar ELJM. Effects of the GABA-uptake inhibitor tiagabine on electroencephalogram, spike-wave discharges and behaviour of rats. Epilepsy Res 1995;21:89-94.
10. Walton NY, Gunawan S, Treiman DM. Treatment of experimental status epilepticus with the GABA uptake inhibitor tiagabine. Epilepsy Res 1994;19:237-44.
11. Schapel G, Chadwick D. Tiagabine and non-convulsive status epilepticus. Seizure 1996;5:153-6.
12. Steinhoff BJ, Stodieck SRG. Temporary abolition of seizure activity by flumazenil in a case of valproate-induced non-convulsive status epilepticus. Seizure 1993;2:261-5.
13. De Krom MCTFM, Verduin N, Visser E, Kleijer M, Scholtes F, de Groen JHM. Status epilepticus during vigabatrin treatment: a report of three cases. Seizure 1995;4:159-62.
14. Macdonald RL. Benzodiazepines. Mechanisms of action. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic drugs. 4th ed. New York: Raven Press. 1995:695-703.
15. Richards DA, Lemos T, Whitton PS, Bowery NG. Extracellular GABA in the ventrolateral thalamus of rats exhibiting spontaneous absence epilepsy: a microdialysis study. J Neurochem 1995;65:1674-80.